Chronic Pelvic Pain Clinical Trial
Official title:
Self-management Intervention for Women With Chronic Pelvic Pain: a Randomized Controlled Trial
NCT number | NCT03617627 |
Other study ID # | DF00800UG |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 23, 2018 |
Est. completion date | April 29, 2019 |
Verified date | March 2020 |
Source | Universidad de Granada |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic pelvic pain is a serious health condition with an estimated prevalence of 15% women worldwide.Treatment is a challenge given the different pain generators described. It is important to develop self-management interventions to reduce the frustration associated with its management.
Status | Completed |
Enrollment | 44 |
Est. completion date | April 29, 2019 |
Est. primary completion date | October 21, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosis of chronic pelvic pain with at least 6 months of evolution Exclusion Criteria: - Active urogenital infection - Pregnancy - Cancer - Dementia - A surgical intervention involving lumbo-pelvic region over the past year |
Country | Name | City | State |
---|---|---|---|
Spain | Department of Physical Therapy | Granada |
Lead Sponsor | Collaborator |
---|---|
Universidad de Granada |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Perceived health-related quality of life | Health-related quality of life will be assessed using the EuroQol-5D. This scale consists of a descriptive system and the EQ visual analogue scale. The descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, oain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. Higher scores indicate more problems. In the visual analogue scale the patient rate the pain from 100 (best imaginable health state) to 0 (worst imaginable health state). Higher values represent a better health state. | Change from baseline health-related quality of life at 7 weeks | |
Primary | Change in coping strategies | Coping strategies will be evaluated using the Coping Strategies Questionnaire (CSQ). It assesses eight different coping strategies for pain which describe two types of coping: adaptive coping (diverting Attention, coping self-statements, ignoring sensations, reinterpreting pain sensation, hoping and cognitive distracting) and maladaptive coping (catastrophizing, and faithing and praying). Participants score each item using a 7-point scale to indicate how often they use that strategy to manage their pain (0 never, 3 sometimes, and 6 always) | Change from baseline coping strategies at 7 weeks | |
Secondary | Change in performance of activities | Canadian Occupational Performance Measure will be used to evaluate changes in patient's self-perception over time including performance and satisfaction scored from 0 to 10. Higher values represented improvement on perceived performance and satisfaction | Change from baseline self-perceived performance at 7 weeks | |
Secondary | Change in activity levels | Activity levels will be evaluated with the International Physical Activity Questionnaire. It assess the frequency and time spent on vigorous, moderate-intensity activities and walking time for each category. Higher values indicate higher activity levels. | Change from baseline self-reported activity levels at 7 weeks | |
Secondary | Change in anxiety levels. | Anxiety will be evaluated using the Beck Anxiety Inventory. It contains 21 questions, each answer being scored on a scale value of 0 (not at all) to 3 (severely). Higher total scores indicate more severe anxiety symptoms. | Change from baseline anxious symptoms at 7 weeks | |
Secondary | Change in depressive symptoms | Depression will be evaluated using the Beck Depression Inventory. It contains 21 questions, each answer being scored on a scale value of 0 (not at all) to 3 (severely). Higher total scores indicate severe depressive symptoms. | Change from baseline depressive symptoms at 7 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03638856 -
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
|
N/A | |
Withdrawn |
NCT03272360 -
Endometriosis Biomarker Discovery Study
|
N/A | |
Completed |
NCT01020162 -
Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT05836454 -
The Soft Tissue Mobilization Techniques on PMS
|
N/A | |
Completed |
NCT02372903 -
Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis
|
N/A | |
Recruiting |
NCT05185180 -
Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
|
||
Recruiting |
NCT05970783 -
A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
|
Phase 3 | |
Completed |
NCT04615247 -
Program to Overcome Pelvic Pain Study
|
N/A | |
Completed |
NCT02721108 -
Mindfulness Meditation for Chronic Pelvic Pain Management
|
N/A | |
Not yet recruiting |
NCT00844012 -
Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain
|
Phase 4 | |
Recruiting |
NCT04976751 -
Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China
|
Phase 1 | |
Withdrawn |
NCT04252040 -
Open Label Extension Study of tDCS Plus Guided Imagery for Women With Chronic Pelvic Pain (CPP)
|
N/A | |
Completed |
NCT01802528 -
Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients
|
N/A | |
Completed |
NCT03175809 -
Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT05324280 -
Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain
|
N/A | |
Not yet recruiting |
NCT02556411 -
Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)
|
N/A | |
Completed |
NCT04104542 -
MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women
|
N/A | |
Completed |
NCT01553201 -
Botulinum Toxin for Pelvic Pain in Women With Endometriosis
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019091 -
Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Pelvic Pain in Adults
|
N/A | |
Terminated |
NCT03541954 -
Neurophysiological Validation of the Clinical Criteria of Sensitization in Chronic Pelvic and Perineal Pain Population
|
N/A |